share_log

Dow Surges Over 100 Points; US Trade Deficit Widens In November

Dow Surges Over 100 Points; US Trade Deficit Widens In November

道指上漲超過100點;美國在11月份的貿易赤字擴大。
Benzinga ·  01/07 10:00

U.S. stocks traded higher this morning, with the Dow Jones index jumping more than 100 points on Tuesday.

美國股票今晨交易價格上漲,道瓊斯指數在週二上漲超過100點。

Following the market opening Tuesday, the Dow traded up 0.30% to 42,833.91 while the NASDAQ gained 0.24% to 19,912.40. The S&P 500 also rose, gaining, 0.30% to 5,993.11.

在週二的市場開盤後,道瓊斯上漲了0.30%,達到42,833.91點,而納斯達克上漲了0.24%,達到19,912.40點。S&P 500也上漲,漲幅爲0.30%,達到5,993.11點。

Leading and Lagging Sectors
Health care shares jumped by 1.1% on Tuesday.

領先和滯後板塊
醫療保健股票在週二上漲了1.1%。

In trading on Tuesday, consumer discretionary shares fell by 0.3%.

在週二的交易中,消費品股票下跌了0.3%。

Top Headline

頭條新聞

The U.S. trade deficit increased to $78.2 billion in November versus a revised $73.6 billion gap in the previous month and mostly in-line with market estimates. Imports increased 3.4% to $351.6 billion, while exports rose 2.7% to $273.4 billion.

美國的貿易逆差在11月增加至782億美金,較上月修正後的736億美元差距有所擴大,基本符合市場預期。進口增加了3.4%,達到3516億美元,而出口增長了2.7%,達到2734億美元。

Equities Trading UP

股票交易上升

  • XTI Aerospace, Inc. (NASDAQ:XTIA) shares shot up 115% to $0.1881.
  • Shares of Hoth Therapeutics, Inc. (NASDAQ:HOTH)got a boost, surging 98% to $1.62 after the company announced safety results from its Phase 2a trial, showing that 100% of patients in Cohort 1 achieved the primary efficacy endpoint.
  • AEye, Inc. (NASDAQ:LIDR) shares were also up, gaining 71% to $3.9901.
  • XTI Aerospace, Inc. (納斯達克:XTIA)的股票上漲了115%,達到了0.1881美元。
  • Hoth Therapeutics, Inc. (納斯達克:HOTH)的股票上漲,飆升98%至1.62美元,此後公司公佈了其2a期試驗的安全結果,顯示第一組的100%患者達到了主要療效終點。
  • AEye, Inc. (納斯達克:LIDR)的股票也上漲,增長71%,達到了3.9901美元。

Equities Trading DOWN

股票交易下跌

  • Acelyrin, Inc. (NASDAQ:SLRN) shares dropped 39% to $2.1270 after the company announced additional Phase 2 data and the Phase 3 program design for lonigutamab in Thyroid Eye Disease. HC Wainwright & Co. cut its price target on the stock from $8 to $6.
  • Shares of Amesite Inc. (NASDAQ:AMST) were down 34% to $2.6800 after the company announced a $3.6 million public offering of 1.2 million shares.
  • Lifeward Ltd. (NASDAQ:LFWD) was down, falling 31% to $2.1095 after the company announced a $5 million registered direct offering.
  • Acelyrin, Inc. (納斯達克:SLRN)的股票下跌39%,至2.1270美元,此後公司公佈了關於lonigutamab在甲狀腺眼病中的額外第二階段數據和第三階段項目設計。HC Wainwright & Co.將該股票的目標價格從8美元下調至6美元。
  • Amesite Inc. (納斯達克:AMST)的股票下跌34%,至2.6800美元,此後公司宣佈了一項360萬美元的120萬股公開發行。
  • Lifeward Ltd. (納斯達克:LFWD)下跌,跌幅達到31%,至2.1095美元,此後公司宣佈了一項500萬的註冊直接發行。

Commodities
In commodity news, oil traded up 1% to $74.26 while gold traded up 1% at $2,672.80.

商品
在商品資訊中,油價上漲了1%,達到74.26美元,而黃金上漲了1%,報2672.80美元。

Silver traded up 0.9% to $30.850 on Tuesday, while copper rose 0.9% to $4.1980.

白銀在星期二上漲了0.9%,達到30.850美元,而銅上漲了0.9%,報4.1980美元。

Euro zone

歐元區:

European shares were mostly higher today. The eurozone's STOXX 600 gained 0.5%, Germany's DAX 40 gained 0.7% and France's CAC 40 climbed 0.9%. Spain's IBEX 35 Index rose 0.3%, while London's FTSE 100 slipped 0.1%.

今天歐洲股市走勢大多向好。歐元區的STOXX 600上漲了0.5%,德國的DAX 40上漲了0.7%,法國的CAC 40上漲了0.9%。西班牙的IBEX 35指數上漲了0.3%,而倫敦的FTSE 100下跌了0.1%。

Asia Pacific Markets

亞太市場

Asian markets closed mostly higher on Tuesday, with Japan's Nikkei 225 gaining 1.97%, China's Shanghai Composite Index gaining 0.71%, Hong Kong's Hang Seng Index declining 1.22% and India's BSE Sensex rising 0.30%.

亞洲市場在星期二大多收高,其中日本的日經225指數上漲了1.97%,中國的上海綜合指數上漲了0.71%,香港的恒生指數下跌了1.22%,而印度的北交所Sensex上漲了0.30%。

Economics

經濟

The U.S. trade deficit increased to $78.2 billion in November versus a revised $73.6 billion gap in the previous month and mostly in-line with market estimates. Imports increased 3.4% to $351.6 billion, while exports rose 2.7% to $273.4 billion.

美國的貿易逆差在11月份增加到782億美元,相對於上個月修正後的736億美元差距,基本符合市場預期。進口增加了3.4%,達到3516億美元,而出口上漲了2.7%,達到2734億美元。

Now Read This:

現在閱讀這個:

  • This Apple Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday
  • 這位蘋果分析師開始看淡;以下是週二的五個主要降級。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論